Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |